About Technology Issues FAQ

Links

Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study

Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.